肠胃康治疗溃疡性结肠炎的临床疗效观察
|
摘要
目的观察肠胃康治疗溃疡性结肠炎的疗效及不良反应。方法选取溃疡性结肠炎患者60例,分为柳氮磺嘧啶组与柳氮磺嘧啶治疗基础上联合肠胃康治疗组(肠胃康组)两组,统计分析两组患者的临床症状及临床疗效。结果和治疗前相比,两组患者治疗后的腹痛、腹泻、脘腹胀满、食少、苔黄腻、粘液便、脓血便、肢体倦怠存在率均显著降低(P<0.05);治疗后和柳氮磺嘧啶组相比,肠胃康组患者的腹痛、腹泻、脘腹胀满、食少、苔黄腻、粘液便、脓血便、肢体倦怠存在率均显著降低(P<0.05);肠胃康组患者治疗的总有效率显著高于柳氮磺嘧啶组(P<0.05)。结论肠胃康治疗溃疡性结肠炎的疗效显著,值得临床推广。
Objective To analyze the efficacy and adverse reactions of Changwei Kang in treatment of ulcerative colitis.Methods 60 cases of patients with ulcerative colitis were randomly divided into two groups,sulfasalazine treatment group was treated with sulfasalazine,on the basis of which Changwei Kang group was treated with Changwei Kang. The clinical symptoms and clinical efficacy of the two groups were statistically analyzed. Results Compared with before treatment,the incidences of abdominal pain,diarrhea,fullness of abdomen,less food,yellow greasy fur,mucous stool,pus and blood stool,limb burnout after treatment of the two groups were significantly lower(P<0.05); compared with sulfadiazine treatment group,the incidences of the above syptoms of Changwei Kang group was significantly lower(P<0.05). The total effective rate of Changwei Kang group was significantly higher than that of sulfasalazine treatment group(P<0.05). Conclusion Changwei Kang is effective in treatment of ulcerative colitis, it is worthy of clinical promotion.
Objective To analyze the efficacy and adverse reactions of Changwei Kang in treatment of ulcerative colitis.Methods 60 cases of patients with ulcerative colitis were randomly divided into two groups,sulfasalazine treatment group was treated with sulfasalazine,on the basis of which Changwei Kang group was treated with Changwei Kang. The clinical symptoms and clinical efficacy of the two groups were statistically analyzed. Results Compared with before treatment,the incidences of abdominal pain,diarrhea,fullness of abdomen,less food,yellow greasy fur,mucous stool,pus and blood stool,limb burnout after treatment of the two groups were significantly lower(P<0.05); compared with sulfadiazine treatment group,the incidences of the above syptoms of Changwei Kang group was significantly lower(P<0.05). The total effective rate of Changwei Kang group was significantly higher than that of sulfasalazine treatment group(P<0.05). Conclusion Changwei Kang is effective in treatment of ulcerative colitis, it is worthy of clinical promotion.
引文
[1]张浩彬.叶柏教授应用阴火理论治疗溃疡性结肠炎的经验[J].中国中医急症,2018,27(4):721-723.
[2]黄彪,谢璐霜,吴巧凤,等.溃疡性结肠炎的中西医治疗进展及思考[J].实用医学杂志,2018,34(13):2267-2269,2274.
[3]郑红斌.我国溃疡性结肠炎诊断标准与日本厚生省标准的比较[J].中国中西医结合消化杂志,2001,9(4):233.
[4]全国慢性感染性肠道疾病医术研讨会.溃疡性结肠炎的诊断及疗效判定标准[J].中医消化杂志,1993,13(6):354.
[5]陈章风,刘宏岩.溃疡性结肠炎的中医研究进展[J].长春中医药大学学报,2018,34(1):196-198.
[6]赵振营,李亚卓,于飞,等.溃疡性结肠炎中药组方规律及整合药理学分子机制探索[J].中草药,2018,49(13):3042-3050.
[7]宁丽琴,叶柏,沈洪,等.国医大师徐景藩治疗溃疡性结肠炎的用药规律分析和分子靶点预测[J].中国中药杂志,2018,43(5):1042-1048.
[8]冯秀云.溃疡性结肠炎治疗中实施中医护理干预的疗效观察[J].中国肛肠病杂志,2018,38(4):68-70.
[9]谢函君,叶志伟.中西医结合治疗溃疡性结肠炎临床观察[J].湖北中医药大学学报,2014,16(6):72-73.
[10]李任重,刘均.中药灌肠治疗慢性溃疡性结肠炎的疗效观察及对血清TNF-和IL-6的影响[J].湖北中医药大学学报,2017,19(1):34-37.
[2]黄彪,谢璐霜,吴巧凤,等.溃疡性结肠炎的中西医治疗进展及思考[J].实用医学杂志,2018,34(13):2267-2269,2274.
[3]郑红斌.我国溃疡性结肠炎诊断标准与日本厚生省标准的比较[J].中国中西医结合消化杂志,2001,9(4):233.
[4]全国慢性感染性肠道疾病医术研讨会.溃疡性结肠炎的诊断及疗效判定标准[J].中医消化杂志,1993,13(6):354.
[5]陈章风,刘宏岩.溃疡性结肠炎的中医研究进展[J].长春中医药大学学报,2018,34(1):196-198.
[6]赵振营,李亚卓,于飞,等.溃疡性结肠炎中药组方规律及整合药理学分子机制探索[J].中草药,2018,49(13):3042-3050.
[7]宁丽琴,叶柏,沈洪,等.国医大师徐景藩治疗溃疡性结肠炎的用药规律分析和分子靶点预测[J].中国中药杂志,2018,43(5):1042-1048.
[8]冯秀云.溃疡性结肠炎治疗中实施中医护理干预的疗效观察[J].中国肛肠病杂志,2018,38(4):68-70.
[9]谢函君,叶志伟.中西医结合治疗溃疡性结肠炎临床观察[J].湖北中医药大学学报,2014,16(6):72-73.
[10]李任重,刘均.中药灌肠治疗慢性溃疡性结肠炎的疗效观察及对血清TNF-和IL-6的影响[J].湖北中医药大学学报,2017,19(1):34-37.